AzTrials
AzTrials

Maternal HealthNCT02517008

The Impact of Non-monetary Incentives on Facility Delivery in Rural Zambia

A study testing Mama kit in people with Maternal Health, run by IDinsight.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study measured the impact and cost-effectiveness of a low-cost, non-monetary incentive ("mama kit") on rural facility delivery rates in Zambia. Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
Conditions the study is for
Maternal Health
What is being tested?
Mama kit
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,159 participants
Where
No sites listed yet
Study dates
Jun 2013to Sep 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Had an antenatal care record at one of the study facilities
  • Had an estimated date of delivery (as measured by estimated date of last menstrual period, estimated date of delivery, or estimated gestational age in weeks as recorded in the antenatal care register) between June 1, 2013 - Aug 31, 2013.

Who cannot join

  • Did not have an antenatal care record at one of the study facilities
  • Had an estimated date of delivery outside of the intervention window (June 1, 2013 - Aug 31, 2013)

About this study

Official title: Measuring the Impact of Non-monetary Incentives on Facility Delivery in Rural Zambia: A Clustered Randomized Controlled Trial

This study measured the impact and cost-effectiveness of a low-cost, non-monetary incentive ("mama kit") on rural facility delivery rates in Zambia.

Read the detailed description

This clustered randomized controlled trial assessed the impact of providing a package of childcare items (a cloth, baby diaper, and blanket) to women conditional upon delivering at a facility on facility delivery rates in rural Serenje and Chadiza Districts in Zambia. Facilities were randomized to either provide the intervention or not. Facility-level antenatal care (ANC) and delivery registers were used to measure the percentage of women attending antenatal care who delivered at a study facility during the intervention period. Results from the trial were then used to model the cost-effectiveness of mama kits at-scale in terms of cost per death averted.

Conditions
Maternal Health
Being tested
Mama kit
Keywords
non-monetary incentive, institutional delivery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mama kitOther

    A low-cost non-monetary incentive (mama kit) was provided to all women who delivered at the facility between June 1, 2013 - Aug 31, 2013. Women were told about the intervention during ANC, and safe motherhood groups in the community promoted the intervention in the catchment areas of the treatment facilities.

Study groups in NCT02517008
Study groupRoleWhat they receive
Mama kits interventionExperimentalHealth facilities randomized to this arm provided mama kits - packages of childcare materials including a cloth ("chitenge"), baby blanket, and diaper - to all mothers who delivered at these facilities between June 1, 2013 - Aug 31, 2013.
Receives: Other: Mama kit
No interventionNo interventionHealth facilities randomized to this arm provided obstetric services as normal.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Facility delivery ratios

    Administrative data were used to measure the outcome. Antenatal care and delivery records were linked across registers. Women who had attended ANC and were linked to a record in the registry was counted as having delivered at a facility.

    Measured: At delivery, up to 10 months after the first antenatal care visit date

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Aug 2015 (estimated)
  2. Study startJun 2013
  3. Primary completionSep 2013
  4. Study completionSep 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
2,159 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02517008
Sponsor's protocol ID
002
Status last verified
Aug 2015
First submitted
27 Jul 2015
Last updated
6 Aug 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Mama kit in people with Maternal Health, run by IDinsight.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Aug 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Facility delivery ratios (time frame: At delivery, up to 10 months after the first antenatal care visit date). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in